Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 35,375 | 23,381 | 19,506 | 17,070 | 14,796 |
| Operating Income | -35,375 | -23,381 | -19,506 | -17,070 | -14,796 |
| Interest Expense | 1,408 | 653 | 167 | 187 | 409 |
| Other Income | -5 | -145 | -2 | -9 | 203 |
| Pre-tax Income | -36,788 | -24,179 | -19,675 | -17,266 | -15,002 |
| Net Income Continuous | -36,788 | -24,179 | -19,675 | -17,266 | -15,002 |
| Net Income | $-36,788 | $-24,179 | $-19,675 | $-17,266 | $-15,002 |
| EPS Basic Total Ops | -0.39 | -0.26 | -0.21 | -0.23 | -0.20 |
| EPS Basic Continuous Ops | -0.39 | -0.26 | -0.21 | -0.23 | -0.20 |
| EPS Diluted Total Ops | -0.39 | -0.26 | -0.21 | -0.23 | -0.20 |
| EPS Diluted Continuous Ops | -0.39 | -0.26 | -0.21 | -0.23 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.26 | -0.21 | N/A | N/A |
| EBITDA(a) | $-35,244 | $-23,249 | $-19,378 | $-16,935 | $-14,663 |